Sex, Age, and Tumor Genetics to Inform Risk Stratification in Papillary Thyroid Cancer

• by Carmelo Nucera

• September 29, 2026

MAPK Inhibitors Restore CAR T-Cell Target in Thyroid Cancer Models

Trametinib and dabrafenib increased TSHR expression and improved the activity of CAR T cells in a patient-derived model of anaplastic thyroid cancer

• September 24, 2026

• 3 min

Correction: Lessons Learned From Implementing a Culturally Tailored Virtual Support Program for Asian American Breast Cancer Survivors With Pain and Depression

• by Seulgi Ryu, Dongmi Kim, Wonshik Chee, Eun-Ok Im

• September 25, 2026

Overall Survival Benefit and Long-Term Safety of Romiplostim in Persistent Chemotherapy-Induced Thrombocytopenia

• by Andrew B. Song, Gerald A. Soff

• September 28, 2026